News on Allos Therapeutics Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Allos Therapeutics Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 13:02:11 GMT en Allos Therapeutics to Present at BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008668&HITNO=0&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008668&THISHREF=http://c.moreover.com/click/here.pl%3fz2521622385%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008668&HITNO=0&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008668&THISHREF=http://c.moreover.com/click/here.pl%3fz2521622385%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Allos Therapeutics to Present at BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006043&HITNO=1&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006043&THISHREF=http://c.moreover.com/click/here.pl%3fz2520569252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006043&HITNO=1&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006043&THISHREF=http://c.moreover.com/click/here.pl%3fz2520569252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Allos Therapeutics to Present at BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005412&HITNO=2&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005412&THISHREF=http://c.moreover.com/click/here.pl%3fz2520357243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005412&HITNO=2&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005412&THISHREF=http://c.moreover.com/click/here.pl%3fz2520357243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Allos Therapeutics to Present at BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007933&HITNO=3&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007933&THISHREF=http://c.moreover.com/click/here.pl%3fz2521342303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007933&HITNO=3&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007933&THISHREF=http://c.moreover.com/click/here.pl%3fz2521342303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: FDA approvals of 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=4&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=4&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: Cancer Highlights of 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945339&HITNO=5&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945339&THISHREF=http://c.moreover.com/click/here.pl%3fz2487052640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945339&HITNO=5&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945339&THISHREF=http://c.moreover.com/click/here.pl%3fz2487052640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOncology Business Review: Celgene Expands In Cancer Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3926137&HITNO=6&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3926137&THISHREF=http://c.moreover.com/click/here.pl%3fz2478080894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3926137&HITNO=6&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3926137&THISHREF=http://c.moreover.com/click/here.pl%3fz2478080894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comI Stock Analyst: Celgene Expands In Cancer Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924892&HITNO=7&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924892&THISHREF=http://c.moreover.com/click/here.pl%3fz2477352364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924892&HITNO=7&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924892&THISHREF=http://c.moreover.com/click/here.pl%3fz2477352364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDaily Markets: New MedPredict Report Highlights Recent Advances in Management of Malignant Hematologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3914374&HITNO=8&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3914374&THISHREF=http://c.moreover.com/click/here.pl%3fz2470963665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3914374&HITNO=8&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3914374&THISHREF=http://c.moreover.com/click/here.pl%3fz2470963665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: BioCentury Publishes Investor Picks for New Biotech Bellwethers in 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886131&HITNO=9&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886131&THISHREF=http://c.moreover.com/click/here.pl%3fz2457642161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886131&HITNO=9&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886131&THISHREF=http://c.moreover.com/click/here.pl%3fz2457642161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Allos Therapeutics to Present at J.P. Morgan Healthcare Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3865019&HITNO=10&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3865019&THISHREF=http://c.moreover.com/click/here.pl%3fz2446190375%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3865019&HITNO=10&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3865019&THISHREF=http://c.moreover.com/click/here.pl%3fz2446190375%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Allos Therapeutics to Present at J.P. Morgan Healthcare Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866391&HITNO=11&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866391&THISHREF=http://c.moreover.com/click/here.pl%3fz2446674421%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866391&HITNO=11&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866391&THISHREF=http://c.moreover.com/click/here.pl%3fz2446674421%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneoushttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3752337&HITNO=12&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3752337&THISHREF=http://c.moreover.com/click/here.pl%3fz2387574503%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3752337&HITNO=12&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3752337&THISHREF=http://c.moreover.com/click/here.pl%3fz2387574503%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Celgene to buy Gloucester in cancer drug dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3746510&HITNO=13&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3746510&THISHREF=http://c.moreover.com/click/here.pl%3fz2385289646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3746510&HITNO=13&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3746510&THISHREF=http://c.moreover.com/click/here.pl%3fz2385289646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3745409&HITNO=14&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3745409&THISHREF=http://c.moreover.com/click/here.pl%3fz2384842857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3745409&HITNO=14&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allos%20Therapeutics%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3745409&THISHREF=http://c.moreover.com/click/here.pl%3fz2384842857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: